Trials / Recruiting
RecruitingNCT06430125
Nephroprotective Effect of Nicorandil in Type 2 Diabetes Mellitus
Clinical Study Evaluating the Nephroprotective Effect of Nicorandil in Patients With Type 2 Diabetes Mellitus
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 46 (estimated)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the possible nephroprotective effect of nicorandil in patients with type 2 diabetes mellitus .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nicorandil 10 MG Oral Tablet | Nicorandil 10 MG oral tablet twice daily |
Timeline
- Start date
- 2023-02-28
- Primary completion
- 2025-02-01
- Completion
- 2025-02-01
- First posted
- 2024-05-28
- Last updated
- 2024-05-28
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06430125. Inclusion in this directory is not an endorsement.